Related Experiment Videos
Longitudinal Analysis of Changes in Deep Learning Image-based Breast Cancer Risk Scores over Time
Constance D Lehman1, Sarah F Mercaldo1, Shadi Azam2
1Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St. WAC 240, Boston, MA 02114.
Radiology
|June 23, 2026
Summary
Artificial intelligence (AI) deep learning (DL) breast cancer risk scores from mammograms increase over time in women who develop cancer, unlike stable scores in cancer-free women. This dynamic change supports AI risk scores as biomarkers for personalized breast cancer screening and prevention.
Area of Science:
- Radiology and Medical Imaging
- Artificial Intelligence in Healthcare
- Oncology and Cancer Research
Background:
- Artificial intelligence (AI)-based deep learning (DL) models offer individualized 5-year breast cancer risk estimates from screening mammograms.
- While validated for static risk prediction, the temporal behavior of these AI risk scores is not well-established.
Purpose of the Study:
- To investigate the longitudinal changes in image-based AI deep learning (DL) risk scores.
- To determine if risk score trajectories differ between women who develop breast cancer and those who remain cancer-free.
Main Methods:
- Retrospective cohort study of 158,807 screening mammograms from 54,014 women (2009-2019).
- Comparison of 817 women diagnosed with breast cancer within one year against cancer-free controls.
- Validated image-only DL model used to generate continuous 5-year risk scores; linear mixed-effects models analyzed score trajectories.
Main Results:
- In women who developed cancer, median AI risk scores increased from 2.1 (6 years pre-diagnosis) to 6.6 (index exam).
- Cancer-free women exhibited stable scores (1.8-2.2) over time.
- Longitudinal analysis showed significant score increases in the cancer group (slope 1.13/year) versus minimal change in controls (slope 0.09/year).
Conclusions:
- AI-based breast cancer risk scores derived from mammograms demonstrate dynamic evolution over time.
- Diverging score trajectories between cancer and cancer-free groups highlight their potential as dynamic biomarkers.
- These findings support the use of AI risk scores for risk-adaptive screening and prevention strategies.